- Business
- FutureTech II Acquisition Corp. (FTIIW) is a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology sector, including artificial intelligence, robotic process automation, biomedical life sciences, and related markets; it offers no current products or services beyond this acquisition mandate. Founded in 2021 and headquartered at 128 Gail Drive in New Rochelle, New York, the company operates as a subsidiary of FutureTech II Partners LLC and targets high-growth technology opportunities primarily in the United States. In August 2025, FutureTech II entered into an amended and restated agreement and plan of merger with Longevity Biomedical Holdings Corp. and Longevity Biomedical, Inc., anticipating closure in the fourth quarter of 2025 subject to stockholder approvals and customary conditions; earlier, in December 2024, it secured a subscription agreement with investor Yuantian Zhang for 1,000,000 shares of Class A common stock at $5.00 per share to support the pending business combination.